Carsten Denkert

机构：Goethe University Frankfurt, Philipps University of Marburg, Universitätsklinikum Gießen und Marburg, German Breast Group, University Hospital Frankfurt, Frankfurt Cancer Institute · ORCID：0000-0002-2249-0982

发表论文 1296 篇 · 总被引 71788 次 · h-index 116

代表论文

• Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trials (2025 · The Lancet Oncology · 被引 7)
• Durvalumab in Combination With Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: Long-Term Analysis From the GeparNuevo Trial (2026 · Journal of Clinical Oncology · 被引 4)
• The Lucerne Toolbox 3: digital health and artificial intelligence to optimise the patient journey in early breast cancer—a multidisciplinary consensus (2025 · The Lancet Oncology · 被引 4)
• Tumour-infiltrating lymphocytes and breast radiotherapy: perspectives from the International Immuno-Oncology Biomarker Working Group (2026 · The Lancet Oncology · 被引 1)
• Manual, digital, and AI tumour-infiltrating lymphocyte scoring: a secondary analysis of the APHINITY randomised trial (2026 · The Lancet Oncology · 被引 1)
• Artificial intelligence-based tumour infiltrating lymphocyte quantification in patients with triple-negative breast cancer: an independent validation study (2026 · The Lancet Oncology · 被引 1)